This compound is a modified nucleoside protected with a phthalimide group, used as a building block in the synthesis of oligonucleotides. It features a cytosine base attached to a modified sugar ring, with the 5'-hydroxyl group masked by the phthalimide moiety for selective deprotection during solid-phase synthesis.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 1220515-69-4
2,4-dichloro-7-cyclopropyl-7H-pyrrolo[2,3-d]pyrimidine
Pharmaceutical intermediate for kinase inhibitors
Acarbose Impurity E
Acarbose impurity reference standard
Acarbose EP Impurity B
Impurity standard for acarbose analysis
(2R,3R)-2-[(benzoyloxy)methyl]-4,4-difluoro-5-oxooxolan-3-yl benzoate
pharmaceutical intermediate
2-[(2R,3S,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-2-(hydroxymethyl)oxolan-3-yl]oxyisoindole-1,3-dione
GSLQDLDOBMUSCB-OUCADQQQSA-N
C1[C@@H]([C@H](O[C@H]1N2C=CC(=NC2=O)N)CO)ON3C(=O)C4=CC=CC=C4C3=O
—